Related Articles
Astragaloside IV attenuates cardiac hypertrophy in rats born from mothers with intrauterine hypoxia through the PKCβII/Egr‑1 pathway
Angiogenic function of astragaloside IV in rats with myocardial infarction occurs via the PKD1‑HDAC5‑VEGF pathway
Intravenous high mobility group box 1 upregulates the expression of HIF‑1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia
Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
Astragaloside IV blocks monocrotaline‑induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling